| Income Statement |
| Total Revenue | 9.65M |
|
| Revenues (USD) | 9.65M |
| Cost of Revenue | 1.57M |
| Gross Profit | 8.08M |
| Operating Expenses | 14.27M |
| Research and Development Expense | 3.86M |
| Selling, General and Administrative Expense | 9.39M |
| Operating Income | -6.18M |
| Net Income | -4.75M |
| Net Income Common Stock | -4.75M |
| Net Income Common Stock (USD) | -4.75M |
| Consolidated Income | -4.75M |
| Earnings per Basic Share | -0.04 |
| Earnings per Basic Share (USD) | -0.04 |
| Earnings per Diluted Share | -0.04 |
| Earning Before Interest & Taxes (EBIT) | -4.75M |
| Earning Before Interest & Taxes (USD) | -4.75M |
| Weighted Average Shares | 106.88M |
| Weighted Average Shares Diluted | 106.88M |
| Balance Sheet |
| Cash and Equivalents | 14.56M |
| Cash and Equivalents (USD) | 14.56M |
| Investments | 133.11M |
| Investments Current | 92.30M |
| Investments Non-Current | 40.81M |
| Trade and Non-Trade Receivables | 4.25M |
| Current Assets | 122.94M |
| Property, Plant & Equipment Net | 27.34M |
| Total Assets | 194.47M |
| Debt Current | 1.37M |
| Total Debt | 17.49M |
| Current Liabilities | 10.21M |
| Debt Non-Current | 16.11M |
| Total Liabilities | 26.59M |
| Accumulated Retained Earnings (Deficit) | -266.23M |
| Shareholders Equity | 167.89M |
| Shareholders Equity (USD) | 167.89M |
| Assets Non-Current | 71.54M |
| Total Debt (USD) | 17.49M |
| Deferred Revenue | 3.27M |
| Goodwill and Intangible Assets | 783.00K |
| Inventory | 7.63M |
| Liabilities Non-Current | 16.38M |
| Trade and Non-Trade Payables | 1.20M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 1.27M |
| Net Cash Flow from Financing | 5.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -5.51M |
| Capital Expenditure | -72.00K |
| Issuance (Purchase) of Equity Shares | 5.00K |
| Net Cash Flow from Investing | 2.66M |
| Net Cash Flow - Investment Acquisitions and Disposals | 2.88M |
| Net Cash Flow from Operations | -8.17M |
| Share Based Compensation | 1.14M |